For the Inventor, By the Inventor

Enter assignee name

White Plains, NY, United States of America

Oligomerix, Inc.

USPTO Granted Patents = 10

% Expired Patents = 40.0

EPO Patents = 3

Forward Citations = 6

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Eliot J Davidowitz (9 out of 9 patents)

James G Moe (9 out of 9 patents)

Allen B Reitz (3 out of 101 patents)

4. Haiyan Bian (3 out of 35 patents)

5. Charles Gluchowski (3 out of 71 patents)

6. James Hendrix (3 out of 8 patents)

7. Albert S Yehaskel (3 out of 3 patents)

8. Mark E McDonnell (3 out of 53 patents)

9. H Marie Loughran (3 out of 9 patents)

10. Patricia Lopez (3 out of 3 patents)

11. Abraham Grossman (1 out of 7 patents)

12. Valentine M Kryukov (1 out of 1 patent)

13. Brian Neil Zeiler (1 out of 1 patent)

14. Marie H Loughran (0 patent)

10 patents: Sort by Forward Citations

1. 12331043 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use (2025-06-17),

2. 12060591 - Tau protease compositions and methods of use (2024-08-13),

3. 11472776 - Quinazolinones that inhibit the formation of tau oligomers and their method of use (2022-10-18),

4. 11306075 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use (2022-04-19),

5. 11104710 - Methods and compositions comprising tau oligomers (2021-08-31),

6. 10597649 - Tau protease compositions and methods of use (2020-03-24),

7. 10465001 - Antibody based reagents that specifically recognize toxic oligomeric forms of tau (2019-11-05),

8. 9506051 - Tau protease compositions and methods of use (2016-11-29),

9. 9464122 - Methods and compositions comprising tau oligomers (2016-10-11),

10. 7232807 - Compositions and methods for binding agglomeration proteins (2007-06-19),

Oligomerix, Inc. is a biopharmaceutical company focused on developing novel therapeutics for Alzheimer's disease and other neurodegenerative disorders. The company's proprietary platform targets tau oligomers, a key pathological hallmark of these diseases. Oligomerix's innovative approach aims to halt the progression of neurodegeneration and improve patients' quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Oligomerix, Inc.

10 Patents

#32 in White Plains, NY

#1,738 in New York

#29,800 in US

#55,915 in the World

White Plains, NY, United States of America

Oligomerix, Inc.

Forward Citations = 6

13 inventors:

Eliot J Davidowitz (9 out of 9 patents)

James G Moe (9 out of 9 patents)

Allen B Reitz (3 out of 101 patents)

4. Haiyan Bian (3 out of 35 patents)

5. Charles Gluchowski (3 out of 71 patents)

Please report any incorrect information to [email protected]

Loading…